Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.
Press releases published on May 7, 2025

GDS to Report First Quarter 2025 Financial Results Before the Open of the U.S. Market on May 20, 2025
SHANGHAI, China, May 07, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will report its …

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader …

Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
- Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC) chemotherapy had increased overall survival, progression free survival, and duration of response compared to patients treated with gemcitabine …

Bitfarms Schedules First Quarter 2025 Conference Call on May 14, 2025
TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global energy and compute infrastructure company, will report its first quarter 2025 financial results on Wednesday, May 14th before the market opens. Management will host a …

Kymera Therapeutics to Participate in Fireside Chat at the BofA Securities 2025 Health Care Conference
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the …

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025
Results from ENLIGHTEN 1 Phase 3 Extension Stage support LYR-210’s favorable safety profile and general consistency with the Primary Study Phase in patients with CRS In the CRS patient subgroup with nasal polyps, analysis showed improvements in both …

Qifu Technology to Announce First Quarter 2025 Unaudited Financial Results on May 19, 2025
SHANGHAI, China, May 07, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced that it will report its unaudited financial …

Planet 13 Announces Release Date of First Quarter 2025 Financial Results
LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced today that it plans to release its financial results for …

Taboola Reports Strong Q1 2025 Financial Results; Results Above High-End of Guidance Across All Key Metrics
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the first quarter ended March 31, 2025. “We’re pleased to start the year off strong, …

Local Energy Savers Wins 2025 Global Recognition Award for Innovation in Energy Efficiency
Photo Courtesy of Local Energy Savers NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Victoria-based energy efficiency company, Local Energy Savers, receives a 2025 Global Recognition Award for innovation and leadership in sustainable solutions. It has …

Monaco: Yachting is reinvented at the Yacht Club, the Energy Boat Challenge returns
MONACO, May 07, 2025 (GLOBE NEWSWIRE) -- In July, Monaco will once again be the center of sustainable yachting innovation. Over 30 teams from 18 countries, expected to surpass 40 by the close of registrations, will gather in the Principality for the 12th …

Fortis Inc. Releases First Quarter 2025 Results
This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, May 07, 2025 …

Oculis to Present at Upcoming May Investor Conferences
ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, …

ENR FutureTech 2025 Day 1 Wrap-Up: AI, Digital Twins, and a Bold Vision for Construction’s Future
SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) -- ENR FutureTech 2025, opened with a high-energy first day that brought together the construction industry’s top innovators, technologists, and visionaries for a packed program of keynotes, panels, and breakout …

Arla Foods Ingredients showcases protein soda concept at Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Consumers are …

Arla Foods Ingredients menampilkan konsep soda protein di Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan menyoroti manfaat fungsional dari pure BLG (beta-laktoglobulin) dalam konsep soda protein baru di Vitafoods Europe. Konsep soda protein Arla Foods Ingredients Konsumen semakin …

Europe Arla Foods Ingredients นำเสนอแนวคิดโซดาโปรตีน ที่งาน Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients จะเน้นคุณประโยชน์เชิงฟังก์ชันของ pure BLG (เบต้า-แลคโตโกลบูลิน) ในแนวคิดโซดาโปรตีนใหม่ที่งาน Vitafoods Europe แนวคิดโซดาโปรตีน Arla Foods Ingredients …